Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 04/03/24 08:00:03 on US and Canada Markets.
2024-04-03 08:00:03 ET Scott Buck from H.C. Wainwright issued a price target of $2.50 for FPAY on 2024-04-03 06:07:00. The adjusted price target was set to $2.50. At the time of the announcement, FPAY was trading at $1.155. The overall price target consensus is at $4.00 ...
2024-04-03 08:00:03 ET Chris Caso from Wolfe Research issued a price target of $31.00 for INTC on 2024-04-03 06:04:00. The adjusted price target was set to $31.00. At the time of the announcement, INTC was trading at $43.94. The overall price target consensus is at $40.7...
2024-04-03 08:00:03 ET Ruben Roy from Stifel Nicolaus issued a price target of $45.00 for INTC on 2024-04-03 06:08:00. The adjusted price target was set to $45.00. At the time of the announcement, INTC was trading at $43.94. The overall price target consensus is at $40.7...
ZUG, Switzerland and BOSTON, April 03, 2024 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team will present at the Annual Needh...
VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- Standard Uranium Ltd. (“ Standard Uranium ” or the “ Company ”) (TSX-V: STND) (OTCQB: STTDF) (Frankfurt: FWB:9SU) is pleased to provide an update on exploration activities on the 19,604-hectare Sun...
Data highlighted in oral presentation at World Vaccine Congress 2024 on April 3, 2024 Early data from patients eligible for evaluation at week 12 show two observations of stable disease, indicating no tumor progression, in VBI-1901 treatment arm (n=2/5; 40% disease control rate [DCR]) By ...
ENVASARC Trial is Fully Enrolled and Final Data are Expected in Third Quarter 2024 SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent Product Development Platform (PDP)...
HOLLYWOOD, Fla., April 03, 2024 (GLOBE NEWSWIRE) -- NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE) , a provider of technology, conformity assessment, and consulting solutions, announced today that it has acquired ASG Engineering Consultants (“ASG...
Infused with AI capabilities, NICE’s CXone WEM is recognized for its focus on the agent experience across digital and voice channels and its commitment to CX innovation NICE (Nasdaq: NICE) announced that TMC , a global, integrated media company, has named NICE...
UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Merus N.V . (Nasdaq: MRUS), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics ® and Triclonics ® ), today announced that Bill Lundberg, M....
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
2.13%Change Percent:
Astellas Pharma Inc. ADR Company Name:
ALPMY Stock Symbol:
OTCMKTS Market: